Schering, a German pharmaceuticals company, is hoping to get approval for a contrastagent whose bubbles, under a correctly tuned ultrasonic beam, will oscillate and eventually rupture.
If the contrastagent was found to be responsible for the deaths, patients at other hospitals might be at risk because it was provided by a third party, the officials warned.